Header Logo

Connection

VALERAE O LEWIS to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications VALERAE O LEWIS has written about Drug Administration Schedule.
VALERAE O LEWIS
Connection Strength
0.021
Drug Administration Schedule
  1. Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.